Cerebral Therapeutics racks up $11 mln Series A
Aurora, Colorado-based Cerebral Therapeutics Inc, a developer of reformulated medications, which bypass the blood brain barrier using chronic implantable infusion systems, has extended its Series A round to $7.8 million. As a result, the company's total Series A funding is $11 million. Cerebral Therapeutics' investors included Granite Point Capital Management LP and Vivo Capital LLC.
8 March 2019•1 min read
